FDA-Inspected Site

Bushu Pharmaceuticals, Ltd.

4 FDA inspections are on record for Bushu Pharmaceuticals, Ltd. in Kawagoe, Japan.

483· Form 483 issued

Kawagoe, Japan · Last updated July 10, 2026

Overview

  • 4 FDA inspections are on record.
  • 4 inspections produced a Form 483.
  • The most recent recorded inspection date is 2022-12-02.

At a glance

Inspections

4

Form 483s

4

EIRs

1

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
28 Nov 2022 – 2 Dec 2022Human Drugs483View 483 →
13 Sep 2016 – 16 Sep 2016Human Drugs483On file
21 Oct 2013 – 25 Oct 2013Human Drugs483On file
15 Jul 2010Not recorded483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

2 Dec 2022
21 CFR 211.160(a)

Following/documenting laboratory controls

Cited by Noreen Muniz

2 Dec 2022
21 CFR 211.160(a)

Following/documenting laboratory controls

Cited by Noreen Muniz

2 Dec 2022
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Noreen Muniz

2 Dec 2022
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Noreen Muniz

2 Dec 2022
21 CFR 211.42(c)

Defined areas of adequate size for operations

Cited by Noreen Muniz

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.160(a)Cited across public-safe Form 483 observations2x
21 CFR 211.22(d)Cited across public-safe Form 483 observations2x
21 CFR 211.42(c)Cited across public-safe Form 483 observations2x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x
21 CFR 211.68(a)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Bushu Pharmaceuticals, Ltd.'s 4 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat